# Bharat Srinivasa

> Bharat Srinivasa is a seed investor at BDC Healthcare Venture backing Therapeutics. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BDC Healthcare Venture](https://shizune.co/investors/profile/bdc-healthcare-fund)
- Location: Toronto, Canada
- Total investments: 5
- Last investment: Jan 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/bsrinivasa
- X (Twitter): https://twitter.com/bharatsrinivasa

Bharat Srinivasa is a seed investor at BDC Healthcare Venture in Toronto focused on Therapeutics and Biotechnology. Dr. Bharat Srinivasa serves as Analyst, Healthcare Venture Fund at BDC Healthcare Venture. He joined BDC Capital in 2015.Before this, he was an associate in the forecasting and valuation practice at Foster Rosenblatt, an international advisory firm focused exclusively on life sciences. Bharat was responsible for providing forecasting, commercialanalytics and pricing & market access analysis.Bharat holds a Bachelor of Science in Biotechnology from the University of Toronto and a Master of Science in Microbiology and Immunology from McGill. He also completed his PhD in Experimental Medicine at McGill University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 2 | 40% |
| Biotechnology | 2 | 40% |
| Medical | 1 | 20% |
| Health Care | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Series A | 1 | 20% |
| Series B | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 2 | 40% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mediar Therapeutics | Mediar Therapeutics is a biotechnology company that develops antibody-based medicines and biologic therapies to address cancer, autoimmune diseases, and other serious health conditions. Its research platform focuses on engineering multi-specific antibodies and modular biologics that can engage multiple biological targets or pathways simultaneously,enabling precise modulation of immune responses. The company’s pipeline includes therapeutic candidates designed to activate or inhibit specific immune functions, with the goal of improving clinical outcomes in oncology and immune-mediated disorders. Mediar Therapeutics also works on scalable manufacturing processes and collaborates with scientific partners to advance its biologics from discovery through clinical development. Its approach integrates protein engineering, immunology, and translational research to create biologic medicines that address complex disease mechanisms. The company continues to refine its technology and expand its therapeutic programs to support future clinical and regulatory progress. | $76M | Series B | Jan 07, 2026 |  |
| Reverb Therapeutics | Reverb Therapeutics engages in the development of treatments for cancer and other diseases. | $12M | Seed | Feb 19, 2025 |  |
| Radiant Biotherapeutics | Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients. | $35M | Series A | Sep 11, 2024 |  |
| Reverb Therapeutics | Reverb Therapeutics engages in the development of treatments for cancer and other diseases. |  | Seed | Nov 15, 2023 |  |
| Radiant Biotherapeutics | Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients. | $8M | Seed | Apr 25, 2023 |  |

5 of 5 investments shown.

## Co-investors
- [FACIT](https://shizune.co/investors/profile/facit-prospects-oncology-fund) — VC Fund, 2 deals together
- [Toronto Innovation Acceleration Partners](https://shizune.co/investors/profile/mars-innovation-mi) — VC Fund, 2 deals together
- [Myeloma Investment Fund](https://shizune.co/investors/profile/myeloma-investment-fund) — VC Fund, 2 deals together
- [Alexandria Real Estate Equities](https://shizune.co/investors/profile/alexandria-real-estate-equities) — VC Fund, 1 deal together
- [Alexandria](https://shizune.co/investors/profile/alexandria-venture) — VC Fund, 1 deal together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together

## About BDC Healthcare Venture

VC Fund · Montréal, Canada

BDC Healthcare Venture is a venture capital firm specializes in healthcare investments. The firm prefers to invest in the innovative therapeutics, medical technology, health technology, prevention, diagnostics, personalized treatment, mobile technologies and services, robotics, automation and disease management sectors.

5 contacts available at BDC Healthcare Venture.

| Name | Title | Profile |
| --- | --- | --- |
| Amine Benmoussa | Principal | https://shizune.co/investors/profile/amine-benmoussa |
| Dion Madsen | Senior Managing Partner | https://shizune.co/investors/profile/dion-madsen |
| Allyson Tighe | Analyst, Healthcare Venture Fund | https://shizune.co/investors/profile/allyson-tighe |
| Bharat Srinivasa | Analyst, Healthcare Venture Fund | https://shizune.co/investors/profile/bharat-srinivasa |
| Ela Borenstein | Managing Partner | https://shizune.co/investors/profile/ela-borenstein |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Bharat Srinivasa invest in?

Bharat Srinivasa invests primarily in Therapeutics, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Bharat Srinivasa last invest?

The most recent investment recorded for Bharat Srinivasa closed in Jan 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co